SUNLENCA

Manufacturer:

GILEAD SCIENCES, INC.

Name:

SUNLENCA

HCPCS Code Descriptor:

Injection, lenacapavir, 1 mg

Category:

J Code

HCPCS:

J1961

NDC(s):

61958-3002-01

Primary Type:

Anti-HIV

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

SUNLENCA is a Anti-HIV drug manufactured by GILEAD SCIENCES, INC. and administered via the Subcutaneous route of administration. The J Code: J1961 is aligned to the drug SUNLENCA.

SUNLENCA belongs to the class of drugs known as capsid inhibitors and affects the capsid of certain viruses hindering their replication process. This medication is often used to treat patients with a virus that causes an autoimmune deficiency. Sunleca is a branded drug manufactured by Gilead Sciences and is currently aligned with the HCPCS code J1961. Patient assistance programs for this medication can be found through Gilead’s Advancing Access program.